FCM
MLTX icon

Farallon Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Farallon Capital Management’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,400
Closed -$205K – 181
2023
Q4 		$205K Buy
+3,400
New +$205K ﹤0.01% 127